Ledger.Open graph →
SEC Form D · Amendment · filed April 21, 2011

Akebia Therapeutics, Inc

Offering
$22.1M
Sold
$13.9M
Exemption
—
Industry
Biotechnology
Location
CINCINNATI, OH
Type
—

People & firms on this filing (16)

Scott K. Wolf · NEW YORK, NYExecMichael W. Perry · Portland, ORDirectorDouglas E. Hailey · NEW YORK, NYDirectorKevin Peters · Cincinnati, OHExecRobert Shalwitz · Cincinnati, OHExecCampbell Murray · Cincinnati, OHDirectorChris J. Littlefield · NEW YORK, NYExecMark E. Scott · DENVER, CODirectorIan Howes · Cincinnati, OHExecPaul Weiss · Cincinnati, OHDirectorJames G. Baughman · DENVER, CODirectorAnupam Dalal · Cincinnati, OHDirectorJosh Sugidono · NEW YORK, NYExecJoseph Gardner · Cincinnati, OHExec · DirectorRichard L. Baum · NEW YORK, NYExec · DirectorJohn Rice · Cincinnati, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗